Here are three high-impact areas where therapy providers could consider deploying AI to maximize their return on investment.
Predicting the outcome of mental health therapy is a vital goal. Statistical models have been used. Now, we turn to using AI ...
Ecopipam, Emalex’s investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with ...
As cell and gene therapy leaders gathered in Maryland to discuss accelerating clinical trials in children, one “cutting edge” ...
Red light therapy is a safe at-home treatment for skin rejuvenation. In this guide, we recommend the best red light therapy masks for visible skin improvement.
Pelvic floor PT is more sophisticated and effective than Instagram makes it seem.
The program, which uses devices inside pint-sized vests that young students wear, aims to boost the quality of teacher-child ...
Ecopipam, Emalex's investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with FDA Orphan Drug and Fast Track designations. The late- ...
Cancer cocktails pairing Moderna’s mRNA-4359 with Merck’s Keytruda and Marengo’s invikafusp alfa with Gilead Sciences’ ...
Researchers found that listening to music embedded with Auditory Beat Stimulation (ABS) significantly reduces acute anxiety, ...
Q1 2026 Earnings Call April 28, 2026 4:30 PM EDTCompany ParticipantsPriya Vedaraman - Senior Vice President of FinanceAnthony Zook ...
Ocugen OCGN is pushing a modifier gene therapy platform across several retinal diseases where current options are limited, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results